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Abstract
Non-typeable Haemophilus influenzae (NTHi) is commonly associated with chronic suppu-
rative lung disease in children. We have previously shown that children with chronic suppu-
rative lung disease have a reduced capacity to produce IFN-γ in response to NTHi
compared with healthy control children. The aim of this study was to determine if deficient
NTHi-specific IFN-γ production is associated with heightened systemic or airway inflamma-
tion. We measured a panel of cytokines (IFN-γ, IL-1β, IL-6, IL-8, IL-12 p70), antimicrobial
proteins (LL-37, IP-10) as well as cellular and clinical factors associated with airway and
systemic inflammation in 70 children with chronic suppurative lung disease. IFN-γ was mea-
sured in peripheral blood mononuclear cells challenged in vitro with live NTHi. Regression
analysis was used to assess the association between the systemic and airway inflammation
and the capacity to produce IFN-γ. On multivariate regression, NTHi-specific IFN-γ produc-
tion was significantly negatively associated with the BAL concentrations of the inflammatory
cytokines IL-6 (β=-0.316; 95%CI -0.49, -0.14; p=0.001) and IL-1β (β=-0.023; 95%CI -0.04,
-0.01; p=0.001). This association was independent of bacterial or viral infection, BAL cellu-
larity and the severity of bronchiectasis (using modified Bhalla score on chest CT scans).
We found limited evidence of systemic inflammation in children with chronic suppurative
lung disease. In summary, increased local airway inflammation is associated with a poorer
systemic cell-mediated immune response to NTHi in children with chronic suppurative lung
disease. These data support the emerging body of evidence that impaired cell-mediated im-
mune responses and dysregulated airway inflammation may be linked and contribute to the
pathobiology of chronic suppurative lung disease.
PLOS ONE | DOI:10.1371/journal.pone.0129517 June 12, 2015 1 / 10
a11111
OPEN ACCESS
Citation: Pizzutto SJ, Upham JW, Yerkovich ST,
Chang AB (2015) High Pulmonary Levels of IL-6 and
IL-1β in Children with Chronic Suppurative Lung
Disease Are Associated with Low Systemic IFN-γ
Production in Response to Non-Typeable
Haemophilus influenzae. PLoS ONE 10(6):
e0129517. doi:10.1371/journal.pone.0129517
Academic Editor: John S Tregoning, Imperial
College London, UNITED KINGDOM
Received: December 14, 2014
Accepted: May 8, 2015
Published: June 12, 2015
Copyright: © 2015 Pizzutto et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: SP is funded by an Australian National
Health and Medical Research Council postgraduate
scholarship (1038415). AC receives funding from an
Australian National Health and Medical Research
Council practitioner fellowship (545216). JU receives
funding from an Australian National Health and
Medical Research Council practitioner fellowship
(511019). This study was supported by the NHMRC
Centre for Research Excellence for Lung Health in
Introduction
Chronic suppurative lung disease (CSLD) is commonly encountered in paediatric respiratory
clinics globally. CSLD is characterised by persistent wet cough and recurrent lower respiratory
infections and neutrophilic inflammation in the airways. CSLD shares many clinical character-
istics with and is thought to be a common antecedent of bronchiectasis [1]. Thus studying
CSLD in young children may provide important insight into the pathogenesis
of bronchiectasis.
Non-typeable Haemophilus influenzae (NTHi) is a common and important respiratory
pathogen associated with CSLD/bronchiectasis [2–4]. Accumulating evidence from studies in
adults [5,6] and children [7,8] suggest that a low capacity for IFN-γ production in response to
NTHi may contribute to the cycle of infection and inflammation associated with the pathogen-
esis of bronchiectasis. Understanding the mechanisms that contribute to impaired immune re-
sponses and the pathogenesis of CSLD are important for the development of intervention
therapies. The mechanisms leading to the impaired NTHi-driven IFN-γ response described in
children and adults have not been investigated. The innate immune response helps drive the
adaptive immune response (e.g. NTHi-driven IFN-γ response) however, our previous work
showed limited evidence of impaired innate immune responses to NTHi in children with
CSLD/bronchiectasis [8]. Thus, the current study focuses on possible downstream factors asso-
ciated with impaired systemic NTHi-driven IFN-γ responses.
There is a growing body of evidence that persistent airway or systemic inflammation may
contribute to impaired T-cell responses. Severe acute inflammation and chronic infection can
disrupt macrophage and T-cell activation and subsequently induce an environment of immune
tolerance or exhaustion [9,10]. Furthermore, it is increasingly recognised that lung and system-
ic immune responses may be inter-related [11,12]. Given these associations, in this prospective
study involving 70 young children with CSLD/bronchiectasis, we investigated whether inflam-
mation (local and systemic) is related to the capacity to produce IFN-γ in response to NTHi.
We hypothesised that an impaired systemic ability to produce IFN-γ in response to NTHi is as-
sociated with lung or systemic inflammation. The most notable finding from this study was
that NTHi-specific IFN-γ production by blood mononuclear cells was associated
with inflammation.
Materials and Method
Study participants
Children 10 years of age with CSLD, undergoing chest high resolution computed tomogra-
phy (HRCT) and flexible bronchoscopy for suspected bronchiectasis, were prospectively re-
cruited (2010–2013) from the Royal Darwin Hospital, Northern Territory, Australia. All
children were clinically stable (defined as absence of recent exacerbation) and under the care of
a specialist paediatrician at the time of sample collection. Radiographic diagnosis of bronchiec-
tasis was made by the respiratory paediatrician (AC) and the severity of bronchiectasis scored
using a modified Bhalla scale as previously done [13]. The total score was the sum of the score
for each lobe, including lingula, based on the extent of bronchiectasis, bronchial wall thickness
and dilation (maximum score 48). Routine clinical investigations [14] were undertaken in all
children evaluated for bronchiectasis. Clinical and socio-demographic data were collected
using standardised data collection forms. Blood and bronchoalveolar lavage (BAL) for clinical
and research investigations were collected immediately prior to chest CT scan/bronchoscopy
as previously described [8]. This study was approved by the Human Research Ethics
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Committee (Northern Territory Department of Health and Menzies School of Health Re-
search; #07/63) and children enrolled following written informed consent from the parent/
carer.
Sample collection
Peripheral blood mononuclear cells (PBMC) and plasma were collected and stored as previous-
ly described [8]. Briefly, PBMC were isolated from heparinised blood using standard density-
gradient techniques and cryopreserved in liquid nitrogen until use. Matched plasma was stored
at -80°C.
BAL was collected and processed as previously described [15]. Briefly, BAL was collected as
two separate aliquots from the most affected lobe and maintained on ice for up to 3 hours prior
to processing. The first aliquot was used for microbiologic/viral analysis, the second for cytolo-
gy and immunology.
BAL used for bacterial culture was stored diluted 2 fold in skim milk tryptone glucose glyc-
erine broth at -80°C. BAL for viral or bacterial analysis by PCR was stored undiluted at -80°C.
Samples were maintained at -80°C prior to testing.
Microbiology/virology Investigations
Semi-quantitative culture identification of Haemophilus influenzae, Streptococcus pneumoniae
andMoraxella catarrhalis from BAL were performed by our research laboratory and a thresh-
old of>104 CFU/ml considered clinically important [3,16]. Pseudomonas aeruginosa and Kleb-
siella pneumoniae culture and identification were performed by the diagnostic laboratory at the
Royal Darwin Hospital. Presence of Chlamydia pneumoniae,Mycobacteria pneumoniae and
the respiratory viruses (rhinovirus, adenovirus, enterovirus, bocavirus, respiratory syncytial
virus, Wu virus, Ki virus, coronavirus, parainfluenzae and metapneumovirus) were determined
by PCR by the Queensland Paediatric Infectious Disease Laboratory as previously done [17].
PBMC investigations
PBMC were challenged with a single strain of NTHi as previously described [8]. Briefly, PBMC
were cultured with live NTHi, PHA (positive control) or medium alone (base line control) for
72 hours, as a reflection of memory T cell function and IFN-γmeasured in the
harvested supernatant.
Quantification of systemic and airway Inflammatory markers
Routine clinical investigations (eg full blood count including white cell count, platelets, C-
reactive protein (CRP) and serum protein) [1] were performed using the regional reference lab-
oratory Royal Darwin Hospital.
IFN-γ, IL-1β, IL-6, IL-8, IL-12 p70, LL-37and IP-10 in plasma and BAL, and IFN-γ and in
PBMC culture supernatants were measured in our research laboratory using an in-house disso-
ciation-enhanced lanthanide fluorescent immunoassay (DELFIA) as described previously
[7,18]. Quantitative standard curves were generated from serial dilutions of recombinant
human proteins and included on each plate. The limit of detection was 10 pg/ml. The cathelici-
din LL-37 was measured in plasma and BAL using a high sensitivity ELISA kit (Hycult Biotech,
The Netherlands). The limit of detection was 0.14 ng/ml. For analysis purposes, a value of 1/10
the limit of detection was assigned if the marker concentration was below the limit
of detection.
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Data analyses
Data were analysed using the statistics package STATA 13 (StataCorp, USA). As the data did
not follow a normal distribution, group data was described as median with interquartile range
(IQR). Differences between groups were assessed using the Mann-Whitney U test. A two-tailed
p-value 0.05 was considered significant. Univariate regression analysis was used to assess the
potential of systemic and airway inflammatory markers and clinical factors to predict in vitro
NTHi-specific IFN-γ production. NTHi-specific IFN-γ concentration was natural log trans-
formed prior to regression analysis. Variables with a p value<0.1 were included in a multivari-
ate regression model. Within this multivariate model, a p value of<0.05 was considered an
independent predictor of the capacity to produce IFN-γ in vitro in response to NTHi.
Results
Characteristics of the children in the cohort
The majority of the 70 children in this study (Table 1) were young, with 84% of the children
aged< 48 months. All but 3 children had radiographic evidence of bronchiectasis and of these,
68% had 3 or more lobes affected. The aetiology of bronchiectasis was presumed to be post-
infectious as more than 80% of the children had been hospitalised at least once and 50% hospi-
talised at least twice for a lower respiratory infection. None of the children had primary
immune deficiencies.
Airway neutrophilia (>15%) was found in 41% of children. A clinically important level of
bacterial infection (>104 cfu/ml BAL) was present in 20 children (28%) and one or more viral
pathogens detected in 30 (44%). Non-typeable H. influenzae (15.5%), S. pneumoniae (15.5%)
and rhinovirus (29.4%) were the most common pathogens identified (detailed microbiology is
presented in S1 Table).
BAL neutrophil % was not significantly associated with the presence of any bacteria (β =
0.19, 95%CI -12.8–13.2; p = 0.98,) or virus (β = 11.44, 95%CI -0.335–23.2; p = 0.057). However,
BAL eosinophil % was significantly and positively associated with viral infection (β = 2.534,
Table 1. Demographic characteristics and respiratory history of the cohort.
Variable N = 70
Age, months, median (IQR) 27 (19–40)
Male, n (%) 39 (55.7)
Indigenous, n (%) 65 (92.9)
Gestational age (n = 66), weeks; median (IQR) 38 (35–40)
Bronchiectasis, number of children (%) 68 (95.8)
number of lobes, median (IQR) 3 (2–4)
§Severity score, median (IQR) 7 (5–10)
Chronic suppurative otitis media, n (%) 9 (12.9)
History of hospitalisation (respiratory), n (%) 59 (84.3)
Number of hospitalisations, median (IQR) 2 (1–3)
Age at ﬁrst hospitalisation, months, median (IQR) 6 (3–9)
Respiratory vaccinations up to date, n (%) 70 (100)
Passive cigarette smoke exposure (n = 52), n (%) 42 (80.8)
Family history asthma (n = 48), n (%) 23 (47.9)
§ scored according to a modiﬁed Bhalla scale as previously reported [13].
doi:10.1371/journal.pone.0129517.t001
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95%CI 0.414–4.654; p = 0.020). BAL IL-1β, IL-6, IL-8 and IP-10 significantly correlated with
BAL % neutrophils but not with BAL % eosinophils (S2 Table).
Relationship of airway and systemic profiles with NTHi-specific IFN-γ
production
On univariate analysis for the BAL data (Table 2 and Fig 1), % neutrophils, IL-1β, IL-6, IL-8,
IP-10, NTHi infection and respiratory viruses were inversely associated with NTHi-specific
IFN-γ production by blood mononuclear cells.
Table 2. Cellular, cytokine andmicrobiologic characteristics of bronchoalveolar lavage from children with CSLD and the association (univariate
regression analysis) between the BALmarkers of inflammation and NTHi-driven IFN-γ production by bloodmononuclear cells.
BAL variable median (IQR) β 95% CI p value
Total cell count x106/ml, 0.36 (0.22–0.50) -0.071 -0.222, 0.079 0.347
Neutrophil % 11 (4.6–39) -0.023 -0.041, -0.005 0.015
Lymphocyte % 0 (0–0.7) -0.081 -0.310, 0.149 0.485
Eosinophil % 2 (0.3–4.0) -0.016 -0.122, 0.089 0.80
# IFN-γ pg/ml 1.0 (1.0–16.9) -0.228 -0.938; 0.481 0.52
# IL-1β pg/ml 133.6 (44.6–1279.4) -0.026 -0.039, -0.012 <0.001
# IL-6 pg/ml 47.2 (19.3–77.8) -0.349 -0.539, -0.158 0.001
# IL-8 pg/ml 105.4 (30.5–547.7) -0. 067 -0.141, 0.008 0.078
# IL-12 p70 pg/ml 27.2 (1–63.6) 0.178 -0.401, 0.757 0.54
# IP-10 pg/ml 340.7 (52.7–604.6) -0.044 -0.067, -0.020 <0.001
# LL-37 ng/ml 2.6 (1.9–4.2) -0.275 -0.921, -0.371 0.40
Pos for any bacterial pathogen, n (%) 20 (28.1) -0.2686 -1.298, 0.0761 0.60
H. inﬂuenzae (non-typeable) 11 (15.5) -1.223 -2.4689, 0.022 0.054
Pos for any viral pathogen, n (%) 20 (29.4) -0.5244 -1.564, 0.516 0.318
Rhinovirus 20 (29.4) -0.5244 -1.564, 0.516 0.318
# β and conﬁdence intervals reported as 100x concentration.
doi:10.1371/journal.pone.0129517.t002
Fig 1. Shows the univariate regression model of NTHi-driven IFN-γ production by bloodmononuclear cells and IL-1β a) and IL-6 b) concentration
in the bronchoalveolar lavage fluid. As the multivariate analyses showed that only IL-1γ and IL-6 were independently associated with the capacity for
NTHi-driven IFN-γ production, other BAL mediators are not shown in the figure.
doi:10.1371/journal.pone.0129517.g001
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On univariate analysis for the systemic inflammation data (Table 3), blood platelet levels
(although within the normal clinical reference range) were inversely associated with NTHi-
specific IFN-γ production by blood mononuclear cells. In contrast, blood leukocyte numbers,
CRP and serum inflammatory mediators were not associated with NTHi-specific IFN-
γ production.
Multivariate analyses
Using a cut off of p<0.1 from the univariate analyses described in Tables 2 and 3 above and
considering confounding factors, we combined the inflammatory markers in the BAL and
blood into a multivariate linear regression model. We found that in vitro IFN-γ production by
blood mononuclear cells in response to NTHi was significantly and inversely associated with
BAL IL-1β (β = -0.023; 95%CI -0.04, -0.01; p = 0.001) and IL-6 (β = -0.316; 95%CI -0.49, -0.14;
p = 0.001). In contrast, BAL IL-8, IP-10, neutrophil % and infection status, as well as blood
platelets were no longer independent predictors of the IFN-γ response to NTHi by blood
mononuclear cells
Discussion
This study is the first to investigate the association between the systemic cell-mediated immune
response and airway inflammation in children with CSLD. Our study of 70 children found that
a reduced capacity for systemic NTHi-specific IFN-γ production was significantly associated
with heightened airway inflammation as shown by high concentrations of IL-1β and IL-6 in
BAL fluid. We found limited evidence of systemic inflammation in this cohort and neither
markers of systemic inflammation or clinical markers of CSLD severity (including radiological
scores of bronchiectasis and socio-demographic factors) predicted the capacity of the systemic
NTHi-specific cell-mediated immune response. These data support the hypothesis that system-
ic adaptive immune responses are linked to persistent airway inflammation in children suscep-
tible to lower respiratory infections.
Table 3. Cellular, cytokine and clinical characteristics of blood from children with CSLD and the association (univariate regression analysis) be-
tween the systemic markers of inflammation and NTHi-driven IFN-γ production by bloodmononuclear cells.
Blood variable median (IQR) β 95% CI p value
White cell count x109/L 11.4 (9.1–14.3) 0.013 0.002, 0.029 0.087
Neutrophil 4.1 (2.85–5.55) -0.064 -0.222, 0.095 0.42
Lymphocyte 4.9 (3.65–6.25) -0.005 -0.143, 0.134 0.95
Eosinophil 0.9 (0.5–1.4) 0.311 -0.122, 0.744 0.16
CRP (n = 36) mg/L 1 (1–3.3) -0.013 -0.061, 0.035 0.59
Protein g/L 73 (70–77) 0.009 -0.058, 0.075 0.80
Platelets x109/L 337 (274.5–377.5) -0.006 -0.010, -0.001 0.017
#IFN-γ pg/ml 26.6 (16.9–97.5) 0.074 -0.102, 0.251 0.40
#IL-1β pg/ml 144.4 (16.7–349.2) -0.012 -0.089, 0.066 0.77
#IL-6 pg/ml 5.7 (1.0–19.4) 1.015 -0.621, 2.651 0.22
#IL-8 pg/ml 11.6 (1.0–17.8) -0.111 -4.099, 3.876 0.96
#IL-12 p70 pg/ml 40.1 (15.3–206.5) 0.037 -0.127, 0.201 0.65
#IP-10 pg/ml 756.8 (506.6–1079.7) -0.030 -0.135, 0.074 0.56
#LL-37 ng/ml 28.9 (22.0–38.3) 0.033 -0.404, 0.470 0.88
# β and conﬁdence intervals reported as 100x concentration.
doi:10.1371/journal.pone.0129517.t003
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The primary strength of our study is the inclusion of a relatively large number of young chil-
dren with lung samples. There are few such published studies and none in children. Child-
based studies are important, as in adult studies of chronic infection it is difficult to know if the
measured immune responses are cause or effect. Our earlier study[8] documented a log-fold in-
crease in IFN-γ production between healthy controls aged<18 months compared to those
>18 months, consistent with normal maturation of the Th1 response through early childhood.
However, in the CSLD group, we found a significantly lower capacity for IFN-γ production
over the same age dynamic. Thus, early childhood studies, such as ours, may provide critical in-
formation regarding inflammation and the development of the adaptive immune response.
Indications of airway inflammation include changes in cellular profile and the presence of
pro-inflammatory cytokines in the BAL or sputum. In adults and children with suppurative
lung disease, airway inflammation is characterised by elevated levels of neutrophils, IL-1β, IL-6
and IL-8 [11,19,20]. Thus, we chose to focus on these cytokines. We found that, in our cohort
of young children with CSLD, IL-1β, IL-6, IL-8 as well as IP-10 and LL-37 in the BAL were sig-
nificantly correlated with BAL neutrophils. These markers of inflammation also negatively cor-
related with systemic NTHi-specific IFN-γ production on univariate analysis. However, on
multivariate regression, only IL-6 and IL-1β were significantly and independently associated
with NTHi-specific IFN-γ production.
The mechanism driving the relationship described is likely complex. The capacity for IFN-γ
production was inversely associated with airway inflammation but the direction of this associa-
tion (i.e. cause or effect) is unknown. One possible mechanism for the former involves regulat-
ing the transition between the inflammatory and adaptive response. These processes are
integral for homeostasis through rapid identification and elimination of the invading pathogen
and prompt resolution of inflammation, measured by markers such as IL-1β and IL-6.
IL1-β, produced by a variety of pulmonary cells in response to a microbial challenge, drives
the inflammation cascade, localises neutrophils and promotes the production of inflammatory
modulators, such as IL-6 and IP-10 production [21]. Consistent with this, we found a strong
correlation between levels of BAL IL-1β, IL-6 and IP-10 in children with CSLD. IL-6 plays a
complex role in the inflammatory response, from promoting inflammation to wound healing.
Dysregulation of IL-6 is associated with chronic inflammation). In addition to its inflammatory
modulating properties, IL-6 is integral to initiating the adaptive response and in directing its
primary phenotype. In the lung, IL-6 polarises the adaptive immune response in favour of the
humoral response. Animal and in vitro studies indicate this is accomplished in two ways. First-
ly, dendritic cell-derived IL-6 suppresses activation of the Th1 pathway by inhibiting IL-12 pro-
duction [22,23]. Secondly IL-6, in synergy with macrophage-derive IP-10, promotes the
differentiation of B-cells into antibody-producing plasma cells [24]. Minimal numbers of lym-
phocytes in our BAL samples precluded our ability to study airway cells directly, however our
data are consistent with the hypothesis that localised immune responses may not be contained
to the lungs. We found that IL-1β, IL-6 and IP-10 were positively correlated with each other.
Furthermore BAL IL-1β was positively associated with BAL IL-13. An environment high in
these cytokines is conducive to a polarised humoral immune response. Thus it is plausible that
the low systemic capacity for NTHi-specific IFN-γ production, also associated with BAL IL-1β
and IL-6, may be a reflection of prolonged humoral responses in the lungs.
An alternative explanation for our finding regarding the association between increased local
(BAL) inflammation and the poorer systemic adaptive response is that insufficient IFN-γmay
contribute to increased susceptibility to infections with NTHi and subsequently a heightened
state of local inflammation. There is increasing evidence to indicate that a strong systemic IFN-
γ response is associated with protective immunity against NTHi [5,8] An impaired ability to
produce sufficient IFN-γ in response to a challenge by NTHi may lead to an increased
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susceptibility to respiratory infections and prolonged inflammation due to ineffective clearing
mechanisms. While the current cross-sectional study has found no relation between NTHi-
specific IFN-γ production and severity of bronchiectasis, resolving this issue will require pro-
spective studies examining the relationship between capacity for IFN-γ production and
clinical outcomes.
We found limited evidence of systemic inflammation in our cohort of young children.
There were isolated exceptions but overall, clinical markers of systemic inflammation including
CRP, white cell count, neutrophils and platelets were within normal ranges. In contrast, adult
based bronchiectasis studies have described systemic inflammation, although this may be tran-
sient and associated with bacterial infection [11,25]. We found no significant association be-
tween plasma and BAL IL-1β or IL-6 and no significant association between markers of
systemic inflammation and the capacity for NTHi-specific IFN-γ production by blood mono-
nuclear cells. Furthermore, clinical markers of CSLD severity (including radiological scores of
bronchiectasis and socio-demographic factors) did not predict systemic NTHi-specific IFN-γ
production. Thus, in children with CSLD, systemic NTHi-specific IFN-γ production is unlikely
to be a direct consequence of systemic inflammation.
The cross-sectional design of the study meant we were unable to determine how resolution
of airway inflammation affects the systemic NTHi-specific IFN-γ response. Also, minimal
numbers of lymphocytes in our BAL samples precluded our ability to study airway cells direct-
ly. However our data shows a strong association between local inflammation and the systemic
adaptive immune response to NTHi in children susceptible to lower respiratory infections. Fu-
ture studies to identify the mechanisms driving this relationship between the adaptive IFN-γ
response and airway inflammation are required to better inform effective, long-term preven-
tion strategies for children at risk of CSLD. Understanding the nature of this association will
help to determine if improving NTHi immunity would be best achieved by directly boosting
the adaptive IFN-γ response through vaccination or immunotherapy strategies or if improved
adaptive responses may be better realised by targeting IL-1β and IL-6 pathways in the lungs.
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